Young David bought PCSA
January 1, 2026 · Form 4 insider transaction
Young David bought 49 shares of Processa Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 34 days after the transaction.
Direction
Acquired (buy-side)
Shares
49
Price
$0.00
Total value
N/A
InsiderYoung David
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 1, 2026
Filing dateFebruary 4, 2026
Shares owned after8,752
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Distribution of vested restricted shares.